Meeting
2013 ASCO Annual Meeting
Targeting apoptosis and autophagy by a novel bcl-2 inhibitor, GX15-070, in neuroblastoma.
Authors
Herve Sartelet
Centre Hospitalier Universitaire Sainte Justine, Montreal, QC, Canada
Herve Sartelet , Sonia Cournoyer , Anissa Addioui , Assila Belounis , Mona Beaunoyer , Carine Nyalendo , Pierre Teira , Gilles Vassal , Elie Haddad
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 31, 2013 (suppl; abstr 10048)
DOI
10.1200/jco.2013.31.15_suppl.10048
Abstract #
10048
Poster Bd #
38G
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Antitumor activity of indenoisoquinoline inhibitors of topoisomerase 1 (TOP1) via apoptosis and autophagocytosis pathways in animal models.
First Author: Robert J. Kinders
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo.
First Author: Wyatt Potter
Poster
2020 ASCO Virtual Scientific Program
Phase I/II trial assessing hydroxychloroquine and itraconazole in women with advanced platinum-resistant epithelial ovarian cancer (EOC) (HYDRA-01).
First Author: Ainhoa Madariaga
Poster
2017 ASCO Annual Meeting
Inhibition of autophagy sensitizes gastrointestinal stromal tumor cells to TKI/Bcl-2 inhibitors-induced apoptosis.
First Author: Shuchao Zhang